SOLACI-CACI 2021 | SAC-FAC Session

✔️ Watch again the complete SAC-FAC Session in the SOLACI-CACI 2021 Congress.

👨‍🏫 Program:

– SESSION I: Functional Mitral Regurgitation: New Horizons for Transcatheter Therapy

  • 01:06 – Optimal Medical Treatment in Patients with Cardiac Failure and Mitral Regurgitation – Florencia Renedo
  • 12:12 – Ultrasonographic Screening of Patients for Endovascular Therapy – Walter García
  • 25:43 – Mitral Valve Percutaneous Repair. Evidence. An Interventional Cardiologist’s Perspective – Jaime Fonseca

👉🏻 Chairpersons: Session I: Eduardo Perna
👉🏻 Panelists: Agüero, Marcelo – Cursack, Guillermo – Fernández Murga, Arturo – Garófalo, Pablo – Larribau, Miguel – Vigo, Santiago José

SESSION II: Medical Treatment and Revascularization in Patients with Chronic Coronary Syndrome

  • 53:09 – Optimal Medical Treatment – Juan Muntaner
  • 01:04:44 – Non-Invasive Diagnostic Methods – Roxana Campisi
  • 01:16:10 – Endovascular Revascularization – Daniel Berrocal

👉🏻 Chairpersons: Session II: Alejandro Hershson & Alejandro Machaín
👉🏻 Panelists: Comtesse, Daniel – Higa, Claudio – Moreyra, Eduardo – Navarro Estrada, José Luis – Pérez Baliño, Pablo – Tajer, Carlos – Swieszkowski, Sandra


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

Evolution of Small Balloon-Expandable Valves

Small aortic rings (20 mm) have posed a significant challenge for both surgery and transcatheter aortic valve implantation (TAVI) due to their association with an...

TCT 2024 | Asymptomatic Severe Aortic Stenosis: What Should Be our Approach?

Approximately 3% of the population over 65 years old has aortic stenosis. Current guidelines recommend valve replacement for patients with symptoms or an ejection...

TCT 2024 | TRISCEND II

This randomized study included 400 patients; 267 were treated with EVOQUE valve and 133 with optimal medical treatment (OMT). After one-year follow-up, there were no...

TCT 2024 – ACCESS-TAVI: Comparing Percutaneous Access Closure Strategies After TAVI

Vascular access complications following transcatheter aortic valve implantation (TAVI) remain common. However, few studies compare vascular access closure methods.  Based on the CHOICE-CLOSURE and MASH...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Evolution of Small Balloon-Expandable Valves

Small aortic rings (20 mm) have posed a significant challenge for both surgery and transcatheter aortic valve implantation (TAVI) due to their association with an...

TCT 2024 | Asymptomatic Severe Aortic Stenosis: What Should Be our Approach?

Approximately 3% of the population over 65 years old has aortic stenosis. Current guidelines recommend valve replacement for patients with symptoms or an ejection...

TCT 2024 | FAVOR III EUROPA

The study FAVOR III EUROPA, a randomized trial, included 2,000 patients with chronic coronary syndrome, or stabilized acute coronary syndrome, and intermediate lesions. 1,008...